Skip to main content

Is Sarcopenia a Condition, a Disorder, a Disease, or a True Geriatric Syndrome?

  • Chapter
  • First Online:
Sarcopenia

Part of the book series: Practical Issues in Geriatrics ((PIG))

  • 744 Accesses

Abstract

With the emergence of precision [2] and high-definition medicine [3], the interrogative title of this chapter seems obvious. However, it reflects the current state of the art regarding sarcopenia, as a recent literature review has proven [4]. Sarcopenia has been indifferently labeled as a “condition,“ [5–7] “disorder,“ [8] “disease,“ [9] “syndrome,“ [10, 11] or “geriatric syndrome” [12, 13] in the most recent international scientific papers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chute CG. Clinical classification and terminology: some history and current observations. J Am Med Inform Assoc. 2000;7:298–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Precision Medicine Coalition. The personalized medicine report 2017: opportunity, challenges, and the future. 2017. http://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/The-Personalized-Medicine-Report1.pdf. Accessed 25 Jan 2021.

  3. Torkamani A, Andersen KG, Steinhubl SR, Topol EJ. High-definition medicine. Cell. 2017;170:828–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lenchik L, Boutin RD. Sarcopenia: beyond muscle atrophy and into the new frontiers of opportunistic imaging, precision medicine, and machine learning. Semin Musculoskelet Radiol. 2018;22:307–22.

    Article  PubMed  Google Scholar 

  5. Fuggle N, Shaw S, Dennison E, Cooper C. Sarcopenia. Best Pract Res Clin Rheumatol. 2017;31:218–42.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Polyzos SA, Margioris AN. Sarcopenic obesity. Hormones (Athens). 2018;17:321–31.

    Article  Google Scholar 

  7. Papadopoulou SK. Sarcopenia: a contemporary health problem among older adult populations. Nutrients. 2020;12:1293.

    Article  PubMed Central  Google Scholar 

  8. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on sarcopenia in older P, the extended Group for E. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:601.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7:512–4.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bravo-Jose P, Moreno E, Espert M, Romeu M, Martinez P, Navarro C. Prevalence of sarcopenia and associated factors in institutionalised older adult patients. Clin Nutr ESPEN. 2018;27:113–9.

    Article  PubMed  Google Scholar 

  11. Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107.

    Article  CAS  PubMed  Google Scholar 

  12. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee WJ, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CW, Wu CH, Wu SN, Zhang T, Zeng P, Akishita M, Arai H. Sarcopenia in Asia: consensus report of the Asian working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101.

    Article  PubMed  Google Scholar 

  13. Bayraktar E, Tasar PT, Binici DN, Karasahin O, Timur O, Sahin S. Relationship between sarcopenia and mortality in elderly inpatients. Eur J Med. 2020;52:29–33.

    CAS  Google Scholar 

  14. Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14:513–37.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hirschfeld HP, Kinsella R, Duque G. Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int. 2017;28:2781–90.

    Article  CAS  PubMed  Google Scholar 

  16. Hassan EB, Duque G. Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician. 2017;46:849–53.

    PubMed  Google Scholar 

  17. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S–1S.

    Article  CAS  PubMed  Google Scholar 

  18. Clark BC, Manini TM. What is dynapenia? Nutrition. 2012;28:495–503.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13:1–7.

    Article  PubMed  Google Scholar 

  20. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on sarcopenia. J Am Med Dir Assoc. 2011;12:249–56.

    Article  PubMed  Google Scholar 

  21. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547–58.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Rockwood K, Stadnyk K, MacKnight C, McDowell I, Hebert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353:205–6.

    Article  CAS  PubMed  Google Scholar 

  23. Casati M, Costa AS, Capitanio D, Ponzoni L, Ferri E, Agostini S, Lori E. The biological foundations of sarcopenia: established and promising markers. Front Med (Lausanne). 2019;6:184.

    Article  Google Scholar 

  24. Flacker JM. What is a geriatric syndrome anyway? J Am Geriatr Soc. 2003;51:574–6.

    Article  PubMed  Google Scholar 

  25. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55:780–91.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Landi F, Picca A, Calvani R, Marzetti E. Anorexia of aging: assessment and management. Clin Geriatr Med. 2017;33:315–23.

    Article  PubMed  Google Scholar 

  27. Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27:1–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Nakamura K. Locomotive syndrome: disability-free life expectancy and locomotive organ health in a “super-aged” society. J Orthop Sci. 2009;14:1–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord. 2017;16:21.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Martone AM, Marzetti E, Salini S, Zazzara MB, Santoro L, Tosato M, Picca A, Calvani R, Landi F. Sarcopenia identified according to the EWGSOP2 definition in community-living people: prevalence and clinical features. J Am Med Dir Assoc. 2020;21:1470–4.

    Article  PubMed  Google Scholar 

  31. Van Ancum JM, Alcazar J, Meskers CGM, Nielsen BR, Suetta C, Maier AB. Impact of using the updated EWGSOP2 definition in diagnosing sarcopenia: a clinical perspective. Arch Gerontol Geriatr. 2020;90:104125.

    Article  PubMed  Google Scholar 

  32. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older P. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–23.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393:2636–46.

    Article  PubMed  Google Scholar 

  34. Robinson SM, Reginster JY, Rizzoli R, Shaw SC, Kanis JA, Bautmans I, Bischoff-Ferrari H, Bruyere O, Cesari M, Dawson-Hughes B, Fielding RA, Kaufman JM, Landi F, Malafarina V, Rolland Y, van Loon LJ, Vellas B, Visser M, Cooper C, Group EW. Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr. 2018;37:1121–32.

    Article  CAS  PubMed  Google Scholar 

  35. Welch AA. Nutritional influences on age-related skeletal muscle loss. Proc Nutr Soc. 2014;73:16–33.

    Article  CAS  PubMed  Google Scholar 

  36. Billot M, Calvani R, Urtamo A, Sanchez-Sanchez JL, Ciccolari-Micaldi C, Chang M, Roller-Wirnsberger R, Wirnsberger G, Sinclair A, Vaquero-Pinto N, Jyvakorpi S, Ohman H, Strandberg T, Schols J, Schols A, Smeets N, Topinkova E, Michalkova H, Bonfigli AR, Lattanzio F, Rodriguez-Manas L, Coelho-Junior H, Broccatelli M, Delia ME, Biscotti D, Marzetti E, Freiberger E. Preserving mobility in older adults with physical frailty and sarcopenia: opportunities, challenges, and recommendations for physical activity interventions. Clin Interv Aging. 2020;15:1675–90.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int. 2015;96:183–95.

    Article  CAS  PubMed  Google Scholar 

  38. Joanisse S, Nederveen JP, Snijders T, McKay BR, Parise G. Skeletal muscle regeneration, repair and remodelling in aging: the importance of muscle stem cells and vascularization. Gerontology. 2017;63:91–100.

    Article  PubMed  Google Scholar 

  39. Vitale G, Cesari M, Mari D. Aging of the endocrine system and its potential impact on sarcopenia. Eur J Intern Med. 2016;35:10–5.

    Article  CAS  PubMed  Google Scholar 

  40. Guadalupe-Grau A, Carnicero JA, Losa-Reyna J, Tresguerres J, Gomez-Cabrera MD, Castillo C, Alfaro-Acha A, Rosado-Artalejo C, Rodriguez-Manas L, Garcia-Garcia FJ. Endocrinology of aging from a muscle function point of view: results from the Toledo study for healthy aging. J Am Med Dir Assoc. 2017;18:234–9.

    Article  PubMed  Google Scholar 

  41. Tagliaferri C, Wittrant Y, Davicco MJ, Walrand S, Coxam V. Muscle and bone, two interconnected tissues. Ageing Res Rev. 2015;21:55–70.

    Article  CAS  PubMed  Google Scholar 

  42. Delezie J, Handschin C. Endocrine crosstalk between skeletal muscle and the brain. Front Neurol. 2018;9:698.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Grosicki GJ, Fielding RA, Lustgarten MS. Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle Axis. Calcif Tissue Int. 2018;102:433–42.

    Article  CAS  PubMed  Google Scholar 

  44. Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, Maier AB. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10:485–500.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O. Health outcomes of sarcopenia: a systematic review and Meta-analysis. PLoS One. 2017;12:e0169548.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Beaudart C, Locquet M, Reginster JY, Delandsheere L, Petermans J, Bruyere O. Quality of life in sarcopenia measured with the SarQoL(R): impact of the use of different diagnosis definitions. Aging Clin Exp Res. 2018;30:307–13.

    Article  PubMed  Google Scholar 

  47. Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF. Sarcopenia and length of hospital stay. Eur J Clin Nutr. 2016;70:595–601.

    Article  CAS  PubMed  Google Scholar 

  48. Sousa AS, Guerra RS, Fonseca I, Pichel F, Ferreira S, Amaral TF. Financial impact of sarcopenia on hospitalization costs. Eur J Clin Nutr. 2016;70:1046–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors report no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Pierre Michel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Michel, JP., Ecarnot, F., Graf, C. (2021). Is Sarcopenia a Condition, a Disorder, a Disease, or a True Geriatric Syndrome?. In: Veronese, N., Beaudart, C., Sabico, S. (eds) Sarcopenia. Practical Issues in Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-030-80038-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-80038-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-80037-6

  • Online ISBN: 978-3-030-80038-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics